Nucleus RadioPharma Secures AstraZeneca Funding to Advance Personalized Cancer Therapy
Nucleus RadioPharma will use the funds to expand its radiopharmaceutical development, supply, and commercial manufacturing capabilities to support personalized cancer therapy
read more..